Summary
“According to the latest industry research, about 90 percent of drugs that reach clinical stage development never make it to FDA approval and commercialisation; the same applies to diagnostic markers.” One crucial point is that usually, in the early stage of drug...
More information & hyperlinks
Web resources: | http://www.whisense.com/ |